Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesTrough Serum Infliximab: A Predictive Factor Of Clinical Outcome For Infliximab Therapy In Acute Ulcerative Colitis
Gut, 08/10/09
Greenberg GR et al. – For ulcerative colitis patients treated with infliximab, a detectable trough serum infliximab predicts clinical remission, endoscopic improvement, and a lower risk for colectomy. In assessing clinical outcomes to infliximab, the presence of antibodies to infliximab is a surrogate for absent drug.
Related Articles
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis
The European Journal of Health Economics, 10/29/09
Relevance Score: 81%
Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease
Clinical Nutrition, 11/18/09
Relevance Score: 78%
Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09
Relevance Score: 70%
Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09
Relevance Score: 69%
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Gastroenterology, 10/06/09
Relevance Score: 68%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B
Journal of Viral Hepatitis, 12/17/09
Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy
Langenbeck's Archives of Surgery, 12/16/09
The efficacy and safety of telaprevir ? a new protease inhibitor against hepatitis C virus
Expert Opinion on Investigational Drugs, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor